Literature DB >> 3731524

Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.

E M el Amin, E P Wright, A Vlug.   

Abstract

Sera from Sudanese patients with either visceral or mucosal manifestations of infection with Leishmania were investigated to determine the class of antibodies against the causative parasite in an enzyme-linked immunosorbent assay (ELISA) with intact promastigotes as antigen. All patient sera had significantly more IgG and more antiparasite IgG than did control Sudanese or control Dutch sera; little or no IgM or IgA antiparasite antibody activity was detected. When sera specific for the subclasses of IgG were used to detect the anti-promastigote antibodies, these were found in IgG1- and IgG3-specific ELISA but not in those for IgG2 or IgG4.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731524      PMCID: PMC1542154     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Elevated serum IgE and IgG4 in patients with atopic dermatitis.

Authors:  F Shakib; P McLaughlan; D R Stanworth; E Smith; E Fairburn
Journal:  Br J Dermatol       Date:  1977-07       Impact factor: 9.302

2.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

3.  Preparation of antibodies against subclasses of human IgG.

Authors:  P C Goosen; S Van Beekhuizen; C Droogh; G De Lange
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  The quantification of human IgG subclasses in reference preparations.

Authors:  F Klein; F Skvaril; R Vermeeren; A Vlug; W J Duimel
Journal:  Clin Chim Acta       Date:  1985-08-15       Impact factor: 3.786

5.  Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.

Authors:  G E Mortimer; J P Widdowson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

6.  The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis.

Authors:  M Hommel; W Peters; J Ranque; M Quilici; G Lanotte
Journal:  Ann Trop Med Parasitol       Date:  1978-06

7.  Anti-leishmania activity of normal animal sera.

Authors:  H R Rezai; S Ardehali; S Gettner
Journal:  Ann Trop Med Parasitol       Date:  1975-03

8.  Mechanism of lethal effect of human serum upon Leishmania donovani.

Authors:  R D Pearson; R T Steigbigel
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

9.  Serological investigations on Indian kala-azar.

Authors:  A C Ghose; J P Haldar; S C Pal; B P Mishra; K K Mishra
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

10.  Antibody-mediated inhibition of phagocytosis in Leishmania donovani-human phagocyte interactions in vitro.

Authors:  K P Chang
Journal:  Am J Trop Med Hyg       Date:  1981-03       Impact factor: 2.345

View more
  5 in total

1.  Dichotomy of protective cellular immune responses to human visceral leishmaniasis.

Authors:  E A G Khalil; N B Ayed; A M Musa; M E Ibrahim; M M Mukhtar; E E Zijlstra; I M Elhassan; P G Smith; P M Kieny; H W Ghalib; F Zicker; F Modabber; A M Elhassan
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

2.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  A K Ghosh; S Dasgupta; A C Ghose
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.

Authors:  Arlene Caldas; Cecília Favali; Dorlene Aquino; Vera Vinhas; Johan van Weyenbergh; Cláudia Brodskyn; Jackson Costa; Manoel Barral-Netto; Aldina Barral
Journal:  BMC Infect Dis       Date:  2005-12-19       Impact factor: 3.090

5.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.